Biotech
BEVERLY, MA: Company to Seek FDA Guidance to Pursue Phase 2/3 Trial of Kevetrin
...
GEORGE TOWN, GRAND CAYMAN: Findings Support Potential for First Once-Daily Nebulized LAMA in COPD; Initiation of Phase 3 Registrational Trials Planned for 2015
...
LAVAL, QUEBEC: - PBI-4050 compares favorably to Nintedanib in lung fibrosis pre-clinical model - PBI-4050 shown to reduce key pro-fibrotic markers in lung fibrosis - PBI-4050 currently in phase II clinical trial in ...
LAVAL, QUEBEC: - Provides ProMetic with additional cGMP, FDA-licensed manufacturing capacity of up to 250,000 liters of plasma processing per annum - Enables the acceleration of additional IND filings - Technology t ...
VANCOUVER, BRITISH COLUMBIA: Internationally-Recognized Life Sciences Executive Joins the Advisory Board of Canadian Company Specializing in Biomedical Technologies for Obesity & Diabetes
...
NORWOOD, MA: Phase 2 Clinical Study in Cystic Fibrosis Expected to Commence in 3Q 2015
...
GEORGE TOWN, GRAND CAYMAN: Velusetrag Improved Gastric Emptying Time Across All Doses vs. Placebo; Velusetrag Produced a Clinically Meaningful Improvement in Gastric Emptying Time in Both Diabetic and Idiopathic Gastroparetic P ...
SEATTLE, WA: Sixteen Completed Clinical Studies Provide Support for Phase 2 Program
...
